Sheila A. Prindiville

3.7k total citations · 1 hit paper
51 papers, 2.6k citations indexed

About

Sheila A. Prindiville is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Sheila A. Prindiville has authored 51 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Sheila A. Prindiville's work include BRCA gene mutations in cancer (8 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Breast Cancer Treatment Studies (7 papers). Sheila A. Prindiville is often cited by papers focused on BRCA gene mutations in cancer (8 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Breast Cancer Treatment Studies (7 papers). Sheila A. Prindiville collaborates with scholars based in United States, United Kingdom and Netherlands. Sheila A. Prindiville's co-authors include Louis M. Weiner, Andrea Stern Ferris, Martin A. Cheever, Ira Mellman, Lynn M. Matrisian, James P. Allison, Olivera J. Finn, Toby T. Hecht, Jaye L. Viner and Timothy C. Kennedy and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Sheila A. Prindiville

49 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

2009 1.1k citations Martin A. Cheever, James P. Allison et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Sheila A. Prindiville

Since Specialization

Citations

This map shows the geographic impact of Sheila A. Prindiville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila A. Prindiville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila A. Prindiville more than expected).

Fields of papers citing papers by Sheila A. Prindiville

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila A. Prindiville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila A. Prindiville. The network helps show where Sheila A. Prindiville may publish in the future.

Co-authorship network of co-authors of Sheila A. Prindiville

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila A. Prindiville. A scholar is included among the top collaborators of Sheila A. Prindiville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila A. Prindiville. Sheila A. Prindiville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer 2025 ·The Lancet Oncology ·(unknown), Winette T.A. van der Graaf, (unknown), Stefan Aebi, (unknown), Justin E. Bekelman, Thierry Gorlia, Frank Hulstaert, Isabelle Huys, Paul G. Kluetz, Michael J. Morris, Vijay Patil, Sheila A. Prindiville, Richard L. Schilsky, Andrew Thomson, Shaun Treweek, Michael Weller, Mira G. P. Zuidgeest, Valesca P. Retèl, Denis Lacombe	0
2	Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies 2024 ·JNCI Journal of the National Cancer Institute ·Sheila A. Prindiville, Sumithra J. Mandrekar, Neal J. Meropol, Andrea Denicoff, (unknown), Judith A. Hautala, James H. Doroshow	1
3	Approach for reporting master protocol study designs on ClinicalTrials.gov: qualitative analysis 2022 ·BMJ ·(unknown), (unknown), Tony Tse, (unknown), David S. Loose, Gisele Sarosy, Sheila A. Prindiville, Frank W. Rockhold, Deborah A. Zarin	3
4	Characteristics of Breast Ducts in Normal-Risk and High-risk Women and Their Relationship to Ductal Cytologic Atypia 2020 ·Cancer Prevention Research ·David N. Danforth, Armando Filie, Andrew Warner, George W. Wright, Zhonghe Sun, Thomas Ried, Christine T. McGowan, Sheila A. Prindiville	3
5	Digitizing clinical trials 2020 ·npj Digital Medicine ·Omer T. Inan, Pamela Tenaerts, Sheila A. Prindiville, Harmony R. Reynolds, Don S. Dizon, Katharine Cooper‐Arnold, Mintu P. Turakhia, Mark J. Pletcher, Kenzie L. Preston, Harlan M. Krumholz, Benjamin M. Marlin, Kenneth D. Mandl, Predrag Klasnja, Bonnie Spring, Erin Iturriaga, Rebecca Campo, Patrice Desvigne‐Nickens, Yves Rosenberg, Steven R. Steinhubl, Robert M. Califf	199
6	COVID-19, Social Justice, and Clinical Cancer Research 2020 ·JNCI Journal of the National Cancer Institute ·James H. Doroshow, Sheila A. Prindiville, Worta McCaskill‐Stevens, Margaret Mooney, Patrick J. Loehrer	10
7	The National Cancer Institute and Department of Veterans Affairs Interagency Group to Accelerate Trials Enrollment (NAVIGATE): A federal collaboration to improve cancer care 2019 ·Seminars in Oncology ·Sara Schiller, Colleen Shannon, Mary T. Brophy, Andrea Denicoff, Marjorie J. Good, Sheila A. Prindiville, Grant D. Huang	5
8	Small Cell Lung Cancer and the Recalcitrant Cancer Research Act 2017 ·Journal of Thoracic Oncology ·O. Wolf Lindwasser, Peter Ujházy, (unknown), Sheila A. Prindiville	2
9	Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research 2016 ·Clinical Cancer Research ·Stephanie R. Land, Benjamin A. Toll, Carol M. Moinpour, Sandra A. Mitchell, Jamie S. Ostroff, Dorothy K. Hatsukami, Sonia A. Duffy, Ellen R. Gritz, Nancy A. Rigotti, Thomas H. Brandon, Sheila A. Prindiville, Linda Sarna, Robert A. Schnoll, Roy S. Herbst, Paul M. Cinciripini, Scott J. Leischow, Carolyn M. Dresler, Michael C. Fiore, Graham Warren	57
10	Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study 2014 ·Breast Cancer Research ·Gretchen L. Gierach, Hui Li, Jennifer T. Loud, Mark H. Greene, Catherine K. Chow, Lan Li, Sheila A. Prindiville, Jennifer Eng‐Wong, Peter W. Soballe, Claudia Giambartolomei, L. Phuong, (unknown), (unknown), (unknown), Olufunmilayo I. Olopade, Mitchell H. Gail, Maryellen L. Giger	51
11	Interphase Cytogenetics of Sputum Cells for the Early Detection of Lung Carcinogenesis 2010 ·Cancer Prevention Research ·Sheila A. Prindiville, Thomas Ried	13
12	Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer 2010 ·Breast Cancer Research and Treatment ·Gretchen L. Gierach, Jennifer T. Loud, Catherine K. Chow, Sheila A. Prindiville, Jennifer Eng‐Wong, Peter W. Soballe, Claudia Giambartolomei, L. Phuong, (unknown), (unknown), (unknown), Celine M. Vachon, Mitchell H. Gail, Mark H. Greene	29
13	The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research breakdown → 2009 ·Clinical Cancer Research ·Martin A. Cheever, James P. Allison, Andrea Stern Ferris, Olivera J. Finn, (unknown), Toby T. Hecht, Ira Mellman, Sheila A. Prindiville, Jaye L. Viner, Louis M. Weiner, Lynn M. Matrisian	1050
14	Recruitment to a physical activity intervention study in women at increased risk of breast cancer 2009 ·BMC Medical Research Methodology ·Larissa A. Korde, (unknown), Ashley Wilder Smith, David Venzon, Sheila A. Prindiville, Bart Drinkard, Nancy G. Sebring, Marcia Datlow Smith, Jo Anne Zujewski, Jennifer Eng‐Wong	12
15	The influence of a Gene expression profile on breast cancer decisions 2009 ·Journal of Surgical Oncology ·Leonard R. Henry, Alexander Stojadinovic, Sandra M. Swain, Sheila A. Prindiville, (unknown), Peter W. Soballe	77
16	Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling 2007 ·Genetics in Medicine ·Jean Jenkins, (unknown), Eileen Dimond, David J. Liewehr, Seth M. Steinberg, (unknown), Pam Klein, Peter W. Soballe, Sheila A. Prindiville, Ilan R. Kirsch	56
17	The Inhibition and Treatment of Breast Cancer with Poly (ADP-ribose) Polymerase (PARP-1) Inhibitors 2006 ·International Journal of Biological Sciences ·(unknown), Xianyan Wang, Yohei Tominaga, Ruihong Wang, Liu Cao, Wenhui Qiao, Cuiling Li, Xiaoling Xu, Amanda P. Skoumbourdis, Sheila A. Prindiville, Craig J. Thomas, Chu‐Xia Deng	56
18	Diffuse Alveolar Hemorrhage with Underlying Pulmonary Capillaritis in the Retinoic Acid Syndrome 1998 ·American Journal of Respiratory and Critical Care Medicine ·Mark R. Nicolls, Lance S. Terada, Rubin M. Tuder, Sheila A. Prindiville, Marvin I. Schwarz	50
19	Best Practices: Use of a New Outcome Scale to Determine Best Practices 1998 ·Psychiatric Services ·William R. Holcomb, Bernard D. Beitman, (unknown), (unknown), Sheila A. Prindiville	10
20	Hormone Replacement Therapy After Breast Cancer: How Shall We DoNo Harm? 1998 ·Cancer Practice ·Tim Byers, (unknown), (unknown), Sheila A. Prindiville	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact